npj Vaccines
Издатель: Springer Nature · 8 статей
-
Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus disease
npj Vaccines, Published online: 04 November 2026; doi:10.1038/s41541-026-01608-4 Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus disease
-
RTS,S-induced off-target antibody responses in malaria-naïve adults associated with protection against controlled human malaria infection
npj Vaccines, Published online: 24 October 2026; doi:10.1038/s41541-026-01600-y RTS,S-induced off-target antibody responses in malaria-naïve adults associated with protection against controlled human malaria infection
-
SARS-CoV-2 breakthrough infections imprint signatures of enhanced immunity against COVID-19
npj Vaccines, Published online: 23 October 2026; doi:10.1038/s41541-026-01595-6 SARS-CoV-2 breakthrough infections imprint signatures of enhanced immunity against COVID-19
-
Linear cap-independent mRNA vaccines as an emerging vaccine platform
npj Vaccines, Published online: 23 October 2026; doi:10.1038/s41541-026-01577-8 Linear cap-independent mRNA vaccines as an emerging vaccine platform
-
Coordinated serum interferon gamma and IL-15 responses to PfRAS vaccination are associated with protection from malaria
npj Vaccines, Published online: 22 October 2026; doi:10.1038/s41541-026-01611-9 Coordinated serum interferon gamma and IL-15 responses to PfRAS vaccination are associated with protection from malaria
-
Preparation quality and epitranscriptomic modification influence circular RNA vaccine performance
npj Vaccines, Published online: 19 October 2026; doi:10.1038/s41541-026-01581-y Preparation quality and epitranscriptomic modification influence circular RNA vaccine performance
-
Rational engineering of Omp34 loop-based immunogen enhances protection against Colistin-resistant Acinetobacter baumannii
npj Vaccines, Published online: 19 October 2026; doi:10.1038/s41541-026-01609-3 Rational engineering of Omp34 loop-based immunogen enhances protection against Colistin-resistant Acinetobacter baumannii
-
Cross-protection of wildtype and vaccine-derived chikungunya virus antibodies against chikungunya and Mayaro viruses in mice
npj Vaccines, Published online: 17 October 2026; doi:10.1038/s41541-026-01604-8 Cross-protection of wildtype and vaccine-derived chikungunya virus antibodies against chikungunya and Mayaro viruses in mice